Taiwan's Medigen Vaccine Biologics Corp. is accelerating a Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, with the trial expected to produce key safety and efficacy data during the fourth quarter of this year, the company said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
U.S. Senator Jeff Merkley visits Taiwan
11/25/2024 08:31 PM - Politics
DPP's Hung Sun-han becomes labor minister amid agency turmoil
11/25/2024 08:21 PM - Society
Taiwan prosecutors indict surgeon over China organ transplants
11/25/2024 07:46 PM - Business
Taiwan shares see earlier gains eroded before MSCI index changes
11/25/2024 07:10 PM - Culture
Taiwan to hold parade for baseball team after WBSC Premier12 win
11/25/2024 07:03 PM